Alecia Muwonge, ’18, Adjunct Professor of Pharmaceutics and Industrial Science, co-authored a paper that was published in Current HIV Research. The study analyzed chemical design changes caused by resistance associated mutations in combination antiretroviral therapy, used to suppress viral loads in HIV patients. Muwonge also serves as Associate Researcher at the Icahn School of Medicine at Mount Sinai.
